Effects of Dronabinol (Oral THC) on Cannabis Use

Status Completed

Clinical Trial Summary

Study participants received dronabinol (0, 120mg/day and 240mg/day) for 12 consecutive days in a randomized order. During each dronabinol maintenance period they were able to self-administer active or placebo cannabis using either a progressive ratio schedule or choice between cannabis and monetary alternative.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01394185
Study type	Interventional
Source	Johns Hopkins University
Contact
Status	Completed
Phase	Phase 1/Phase 2
Start date	February 2011
Completion date	September 2012

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01081119` - Brief Voluntary Alcohol and Drug Intervention for Middle School Youth	Phase 2
Completed	`NCT00506753` - Motivation and Skills for Delta-9-tetrahydrocannabinol/Ethanol (THC/ETOH+) Teens in Jail	N/A
Completed	`NCT01863095` - An Exercise App to Reduce Young Adults' MJ Use	N/A
Completed	`NCT03518567` - Behavioral Economic Analysis of Demand for Marijuana	Phase 2
Recruiting	`NCT06120855` - Study on Regulated Cannabis Sales in Pharmacies	N/A
Completed	`NCT00743145` - Effects of Low-dose Naltrexone in Combination With a Range of Smoked Marijuana	Phase 2
Completed	`NCT00650585` - An Effectiveness Trial of Project ALERT	N/A
Completed	`NCT01025700` - Nabilone & Marijuana Addiction	Phase 2/Phase 3
Recruiting	`NCT03909477` - Longitudinal Study of Xenon-129 MRI Imaging Effects of Cannabis Smoking
Completed	`NCT01536899` - Medical Marijuana Use in HIV+ Patients Prospective Cohort Study
Completed	`NCT00107562` - Adolescent Safer Sex Social Network Intervention	N/A
Active, not recruiting	`NCT00547963` - Brief Counseling to Reduce Injuries Among Emergency Department Patients Who Report Alcohol and Substance Use	Phase 2/Phase 3
Completed	`NCT00743366` - Effect of Quetiapine on Marijuana Withdrawal and Relapse	Phase 2